109 related articles for article (PubMed ID: 34572290)
1. Betulinic Acid Decorated with Polar Groups and Blue Emitting BODIPY Dye: Synthesis, Cytotoxicity, Cell-Cycle Analysis and Anti-HIV Profiling.
Kodr D; Stanková J; Rumlová M; Džubák P; Řehulka J; Zimmermann T; Křížová I; Gurská S; Hajdúch M; Drašar PB; Jurášek M
Biomedicines; 2021 Aug; 9(9):. PubMed ID: 34572290
[TBL] [Abstract][Full Text] [Related]
2. Mitochondria-targeted betulinic and ursolic acid derivatives: synthesis and anticancer activity.
Nedopekina DA; Gubaidullin RR; Odinokov VN; Maximchik PV; Zhivotovsky B; Bel'skii YP; Khazanov VA; Manuylova AV; Gogvadze V; Spivak AY
Medchemcomm; 2017 Oct; 8(10):1934-1945. PubMed ID: 30108714
[TBL] [Abstract][Full Text] [Related]
3. Alkyl Amine Bevirimat Derivatives Are Potent and Broadly Active HIV-1 Maturation Inhibitors.
Urano E; Ablan SD; Mandt R; Pauly GT; Sigano DM; Schneider JP; Martin DE; Nitz TJ; Wild CT; Freed EO
Antimicrob Agents Chemother; 2016 Jan; 60(1):190-7. PubMed ID: 26482309
[TBL] [Abstract][Full Text] [Related]
4. New Phosphorus Analogs of Bevirimat: Synthesis, Evaluation of Anti-HIV-1 Activity and Molecular Docking Study.
Chrobak E; Marciniec K; Dąbrowska A; Pęcak P; Bębenek E; Kadela-Tomanek M; Bak A; Jastrzębska M; Boryczka S
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31640137
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of a new derivative of bevirimat that targets the Gag CA-SP1 cleavage site.
Coric P; Turcaud S; Souquet F; Briant L; Gay B; Royer J; Chazal N; Bouaziz S
Eur J Med Chem; 2013 Apr; 62():453-65. PubMed ID: 23399723
[TBL] [Abstract][Full Text] [Related]
6. Structure-Activity Relationships of the Human Immunodeficiency Virus Type 1 Maturation Inhibitor PF-46396.
Murgatroyd C; Pirrie L; Tran F; Smith TK; Westwood NJ; Adamson CS
J Virol; 2016 Sep; 90(18):8181-97. PubMed ID: 27384665
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and cytotoxicity of BODIPY FL labelled triterpenoids.
Brandes B; Hoenke S; Fischer L; Csuk R
Eur J Med Chem; 2020 Jan; 185():111858. PubMed ID: 31718946
[TBL] [Abstract][Full Text] [Related]
8. Tuning of the Anti-Breast Cancer Activity of Betulinic Acid via Its Conversion to Ionic Liquids.
Ossowicz-Rupniewska P; Klebeko J; Georgieva I; Apostolova S; Struk Ł; Todinova S; Tzoneva RD; Guncheva M
Pharmaceutics; 2024 Apr; 16(4):. PubMed ID: 38675157
[TBL] [Abstract][Full Text] [Related]
9. Phase I and II study of the safety, virologic effect, and pharmacokinetics/pharmacodynamics of single-dose 3-o-(3',3'-dimethylsuccinyl)betulinic acid (bevirimat) against human immunodeficiency virus infection.
Smith PF; Ogundele A; Forrest A; Wilton J; Salzwedel K; Doto J; Allaway GP; Martin DE
Antimicrob Agents Chemother; 2007 Oct; 51(10):3574-81. PubMed ID: 17638699
[TBL] [Abstract][Full Text] [Related]
10. In vitro resistance to the human immunodeficiency virus type 1 maturation inhibitor PA-457 (Bevirimat).
Adamson CS; Ablan SD; Boeras I; Goila-Gaur R; Soheilian F; Nagashima K; Li F; Salzwedel K; Sakalian M; Wild CT; Freed EO
J Virol; 2006 Nov; 80(22):10957-71. PubMed ID: 16956950
[TBL] [Abstract][Full Text] [Related]
11. The application of water soluble, mega-Stokes-shifted BODIPY fluorophores to cell and tissue imaging.
Moriarty RD; Martin A; Adamson K; O'Reilly E; Mollard P; Forster RJ; Keyes TE
J Microsc; 2014 Mar; 253(3):204-18. PubMed ID: 24467513
[TBL] [Abstract][Full Text] [Related]
12. Lupane and 18α-oleanane derivatives substituted in the position 2, their cytotoxicity and influence on cancer cells.
Borkova L; Gurska S; Dzubak P; Burianova R; Hajduch M; Sarek J; Popa I; Urban M
Eur J Med Chem; 2016 Oct; 121():120-131. PubMed ID: 27236068
[TBL] [Abstract][Full Text] [Related]
13. Fluorescent Labeling of Protein Using Blue-Emitting 8-Amino-BODIPY Derivatives.
Kim D; Ma D; Kim M; Jung Y; Kim NH; Lee C; Cho SW; Park S; Huh Y; Jung J; Ahn KH
J Fluoresc; 2017 Nov; 27(6):2231-2238. PubMed ID: 28823107
[TBL] [Abstract][Full Text] [Related]
14. Promiscuous, Multi-Target Lupane-Type Triterpenoids Inhibits Wild Type and Drug Resistant HIV-1 Replication Through the Interference With Several Targets.
Bedoya LM; Beltrán M; García-Pérez J; Obregón-Calderón P; Callies O; Jímenez IA; Bazzocchi IL; Alcamí J
Front Pharmacol; 2018; 9():358. PubMed ID: 29720939
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and Evaluation of Anticancer Activities of Novel C-28 Guanidine-Functionalized Triterpene Acid Derivatives.
Spivak A; Khalitova R; Nedopekina D; Dzhemileva L; Yunusbaeva M; Odinokov V; D'yakonov V; Dzhemilev U
Molecules; 2018 Nov; 23(11):. PubMed ID: 30453551
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of nandrolone-bodipy conjugates.
Jurášek M; Rimpelová S; Pavlíčková V; Ruml T; Lapčík O; Drašar PB
Steroids; 2015 May; 97():62-6. PubMed ID: 25448362
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of novel benzylidene analogues of betulinic acid as potent cytotoxic agents.
Gupta N; Rath SK; Singh J; Qayum A; Singh S; Sangwan PL
Eur J Med Chem; 2017 Jul; 135():517-530. PubMed ID: 28500966
[TBL] [Abstract][Full Text] [Related]
18. The sequence of the CA-SP1 junction accounts for the differential sensitivity of HIV-1 and SIV to the small molecule maturation inhibitor 3-O-{3',3'-dimethylsuccinyl}-betulinic acid.
Zhou J; Chen CH; Aiken C
Retrovirology; 2004 Jun; 1():15. PubMed ID: 15225375
[TBL] [Abstract][Full Text] [Related]
19. Novel Betulinic Acid-Nucleoside Hybrids with Potent Anti-HIV Activity.
Wang Q; Li Y; Zheng L; Huang X; Wang Y; Chen CH; Cheng YY; Morris-Natschke SL; Lee KH
ACS Med Chem Lett; 2020 Nov; 11(11):2290-2293. PubMed ID: 33214842
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity and modes of action of three naturally occurring xanthones (8-hydroxycudraxanthone G, morusignin I and cudraxanthone I) against sensitive and multidrug-resistant cancer cell lines.
Kuete V; Sandjo LP; Ouete JL; Fouotsa H; Wiench B; Efferth T
Phytomedicine; 2014 Feb; 21(3):315-22. PubMed ID: 24075210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
